Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Multiple Endocrine Neoplasia Type 1 1Inflammation 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Omeprazole 2soybean oil, phospholipid emulsion 1dolutegravir 1Vitamin D 1Tumor Necrosis Factors 1Trimethoprim, Sulfamethoxazole Drug Combination 1Sufentanil 1Sodium Chloride 1Ritonavir 1Riluzole 1Oxycodone 1Nutrition Assessment 1Nucleosides 1Naproxen 1Infliximab 1Fish Oils 1Febuxostat 1Exercise 1Diet 1Dexlansoprazole 1Darunavir 1Colchicine 1Clindamycin 1ClinOleic 1Cephalexin 1Anti-Bacterial Agents 1Allopurinol 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Inflammation × Vitamin D × Clear all
NCT01437696 2014-09-05

How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?

McGill University

Phase 4 Completed
77 enrolled
Endocrine

Inflammation, Vitamin D Deficiency, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡